相关实验视频

Updated: Feb 28, 2026

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

在白内障手术前干眼疾病治疗对折射误差减少的影响

Katarzyna Biela¹, Mateusz Winiarczyk¹, Beata Gumieniak-Goch²

¹Department of Vitreoretinal Surgery, Medical University of Lublin, Chmielna 1, 20079 Lublin, Poland.

Journal of clinical medicine

|February 27, 2026

概括

在白内障手术前优化眼睛表面显著减少折射误差,即使在患有眼睛干燥疾病 (DED) 的患者中也是如此. 术前治疗改善了折射预测能力和结果.

科学领域:

眼科医生眼科眼科
生物医学工程生物医学工程
角质科学角质科学

背景情况:

干眼病 (DED) 影响眼膜的稳定性,影响白内障手术中的眼睛生物识别和折射可预测性.
DED的患病率经常被低估,特别是在老年人群中.
对DED进行不充分的术前治疗可能会导致白内障手术后的折射误差.

研究的目的:

量化DED对白内障手术中折射可预测性的影响.
为了评估是否短,手术前的眼球表面优化可以减少术后折射的平均绝对误差 (MAE).
为了评估眼睛表面优化的有效性,无论DED状态如何.

主要方法:

接受白内障手术的70名患者被分为三个组:有治疗的DED,没有治疗的DED和对照组.
生物测量进行了两次:治疗前和治疗后的治疗组,以及对照组的两周间隔.
在手术后一个月计算了两个生物识别测量的折射误差.

主要成果:

在DED和非DED组中,眼皮表面处理减少了折射误差.
在DED组中,MAE从0.39降至0.27 (p < 0.001),在非DED组中从0.30降至0.24 (p = 0.043).
在DED组中,角膜形是最可变的参数;在不同组中没有观察到显著的生物特征差异.

结论:

眼睛表面的术前优化对于减少术后折射误差至关重要.
在白内障手术之前治疗干眼疾病可以提高折射预测能力.
眼睛表面准备有利于所有接受白内障手术的患者,不论DED状态如何.

关键词:

白内障手术是什么?白内障手术是什么?干眼疾病是干眼的疾病.眼内透镜的功率计算.滋剂滴水滋剂滴水折射结果的折射结果.

更多相关视频

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

$Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity$ 05:46

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity

Published on: September 20, 2024

相关概念视频

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...